Signet Financial Management LLC trimmed its holdings in shares of STERIS plc (NYSE:STE) by 2.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 12,081 shares of the medical equipment provider’s stock after selling 273 shares during the period. Signet Financial Management LLC’s holdings in STERIS were worth $2,301,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Vantage Consulting Group Inc bought a new position in shares of STERIS during the 4th quarter valued at $25,000. Exchange Traded Concepts LLC lifted its holdings in shares of STERIS by 278.4% during the 4th quarter. Exchange Traded Concepts LLC now owns 140 shares of the medical equipment provider’s stock valued at $27,000 after buying an additional 103 shares during the period. Kinloch Capital LLC bought a new position in shares of STERIS during the 4th quarter valued at $36,000. Kings Point Capital Management bought a new position in shares of STERIS during the 4th quarter valued at $38,000. Finally, Veriti Management LLC bought a new position in shares of STERIS during the 4th quarter valued at $38,000. Institutional investors and hedge funds own 90.01% of the company’s stock.
A number of equities analysts recently commented on the company. Raymond James reaffirmed a “hold” rating on shares of STERIS in a report on Wednesday, January 20th. KeyCorp raised their target price on STERIS from $224.00 to $227.00 and gave the stock an “overweight” rating in a report on Wednesday, March 17th. JMP Securities raised their target price on STERIS from $217.00 to $235.00 and gave the stock an “outperform” rating in a report on Tuesday, May 11th. Finally, Zacks Investment Research cut STERIS from a “buy” rating to a “hold” rating and set a $227.00 target price on the stock. in a report on Tuesday, April 27th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. STERIS has a consensus rating of “Buy” and a consensus price target of $223.80.
In other STERIS news, VP Julia Madsen sold 1,000 shares of the firm’s stock in a transaction dated Friday, April 23rd. The stock was sold at an average price of $215.00, for a total transaction of $215,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.20% of the stock is owned by company insiders.
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Story: Margin
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.